HomeBest options strategy › NRIX

Best Options Strategy for NRIX

Di Yojana Mandon · Aggiornato 2026-07-22 · 2 min di lettura · Avvertenza sui rischi

Looking for the best options strategy for Nurix Therapeutics, Inc. (NRIX)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live NRIX option chain right now, and a simple map from your view on NRIX to the strategy that fits it. Model any of them in the calculator before you trade.

About Nurix Therapeutics, Inc.

Nurix Therapeutics is a clinical-stage biopharmaceutical company developing small molecule and antibody drugs aimed at cancer, inflammatory diseases, and other conditions. Its pipeline includes several oral drug candidates at early to mid-stage testing: NX-5948, a BTK degrader in Phase 2 trials for blood cancers and autoimmune disorders; NX-2127, another BTK degrader in Phase 1 development for relapsed or refractory B-cell malignancies; NX-1607, a CBL-B inhibitor in Phase 1 testing for immuno-oncology applications; and NX-0479/GS-6791, an IRAK4 degrader being studied for rheumatoid arthritis and inflammatory conditions. The company has structured its development work around a protein degradation platform targeting cellular pathways involved in disease.

The company operates through partnerships with major pharmaceutical firms. Nurix has signed collaborative agreements with Gilead Sciences, Sanofi, and Pfizer for joint development and commercialization of multiple candidates across its portfolio. These arrangements provide development funding and leverage the partners' scale for eventual market distribution. Founded in 2009 and rebranded as Nurix Therapeutics in 2018, the company…

Today's top-scoring strategy for NRIX

Our engine ranks defined-risk strategies on the live NRIX chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.

Iron Condor neutral
Price: $23.63Implied volatility: 32%Expiration: 2026-08-21 (29d)
ActionQtyTypeStrikePremium
BuyPUT$20$0.03
SellPUT$21$0.10
SellCALL$26$0.15
BuyCALL$27$0.06
P/L at expiry vs today At expiry Today ±1σ
$16$24$31
Profitto massimo
$16
Perdita massima
−$84
Credito netto (incassato)
$16
Punto/i di pareggio
$20.84, $26.16
Position Greeks
Δ
−2.02
Γ
−8.819
Θ
0.69
ν
−1.26
Time decay (price held)
Implied-volatility skew

Simulazione

Simulazione prospettica di 6,000 traiettorie di prezzo lognormali fino alla scadenza — non è un backtest storico.

Percentuale di successo
80%
P/L medio
$0
Mediana
$16
Mov. atteso (1σ)
9%
5° pct
−$84
25° pct
$16
75° pct
$16
95° pct
$16

Analisi della strategia

Traiettorie di prezzo simulate (tempo × prezzo)
now $24BE $21BE $26$20$24$270d15d29d
$-83$-34$15

Greche vs prezzo

Δ — P/L in $ per ogni movimento di $1 del sottostante (esposizione equivalente in azioni).
Θ — P/L in $ al giorno dal decadimento temporale.
ν — P/L in $ per ogni +1% di volatilità implicita.
Γ — quanto velocemente cambia il delta per ogni movimento di $1.

Prezzo × volatilità (oggi)

−30%−15%IV+15%+30%
$30−$79−$75−$71−$68−$65
$28−$69−$64−$60−$57−$54
$27−$48−$45−$43−$42−$41
$26−$21−$23−$24−$26−$28
$25$1−$4−$8−$13−$17
$24$11$6−$0−$6−$12
$22$7$1−$4−$10−$15
$21−$14−$17−$21−$24−$27
$20−$47−$46−$45−$44−$44
$19−$74−$70−$66−$63−$61
$18−$83−$81−$79−$76−$74
Analyze NRIX in the calculator → Share this pick ↗

Illustrative example at NRIX's latest available price, computed with the same engine as the tool. Live option fills and the real IV skew refresh during US market hours.

Implied volatility

NRIX is currently trading with moderate implied volatility, broadly in line with other large-cap stocks. On the options we scanned that was around 32% implied volatility, and higher implied volatility means richer premiums and wider expected moves.

Options on NRIX currently price in about 32% implied volatility, versus roughly 63% the stock has actually realised over the past month. That makes options relatively cheap — an edge for strategies that buy premium, such as long calls, long puts and debit spreads.

Off that volatility, the options market is pricing a move of about ±$2,14 (±9%) in NRIX by 2026-08-21 — a range of roughly $21,49 to $25,77. Strikes inside that band hold most of the premium and see most of the action.

Across strikes, downside puts on NRIX trade at a higher implied volatility than upside calls — the market is paying up for crash protection. That skew favours selling put spreads or buying calls over symmetric trades.

Insider trading su NRIX (SEC Form 4)

Operazioni degli insider sul mercato aperto relative a NRIX negli ultimi sei mesi circa, tratte dalle comunicazioni SEC Form 4. Gli acquisti sul mercato aperto sono il segnale più raro e più forte — le vendite di routine effettuate nell'ambito di piani prestabiliti sono frequenti, quindi leggi un dato di vendita netta tenendolo presente.

Acquisti sul mercato aperto
0 · —
Vendite sul mercato aperto
20 · $2.4M
Netto (acquisti − vendite)
−$2.4M
InsiderAzioneAzioniValoreData
Ring ChristineVendita11.008$259K2026-07-02
Ring ChristineVendita28.935$581K2026-06-25
Hansen GwennVendita5394$108K2026-06-25
Ring ChristineVendita8148$135K2026-06-02
van Houte HansVendita582$10K2026-05-05
van Houte HansVendita13.473$223K2026-05-05

Fonte: comunicazioni SEC Form 4 tramite Finnhub. Solo acquisti (P) e vendite (S) sul mercato aperto — assegnazioni, esercizi di opzioni, donazioni e ritenute fiscali sono esclusi. Contesto informativo, non consulenza sugli investimenti.

Earnings & IV crush

NRIX's next earnings report is due around 8 ottobre 2026. Options that expire after it price in a binary move, so their implied volatility is elevated and usually collapses right after the announcement — an "IV crush". If your expiration falls before this date, the trade sidesteps the event.

Key figures

Market cap
$2.4B
Beta (vs market)
1.80
52-week range
$8.20–$25.09 (91% up the range)
Short interest
17.3% of float · 4.7 days to cover

With 17.3% of NRIX's float sold short, squeeze and gap risk are elevated — one reason its options can stay expensive.

How to choose an options strategy for NRIX

Start with your outlook on NRIX, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:

Bullish

You expect NRIX to rise

Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.

Long Call → Bull Call Spread →

Bearish

You expect NRIX to fall

Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.

Long Put → Bear Put Spread →

Neutral

You expect NRIX to trade in a range

Sell an iron condor to collect premium while NRIX stays between two strikes, or write a covered call against shares you already own.

Iron Condor → Covered Call →

⧉ Embed this free calculator on your site →

How we pick the best strategy

For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →

Open NRIX in the free calculator →

Domande frequenti

What is the best options strategy for NRIX?

It depends on your outlook. Bullish traders often use a long call or bull call spread on NRIX; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.

Are NRIX options liquid enough to trade?

Nurix Therapeutics, Inc. (NRIX) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.

How much money do I need to trade NRIX options?

Buying a single NRIX call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.

Is this financial advice?

No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade NRIX or any security. Do your own research.

Cosa fa Nurix Therapeutics, Inc.?

Nurix Therapeutics, Inc. (NRIX) opera nel settore Biotechnology. La sezione "Informazioni su Nurix Therapeutics, Inc." qui sopra offre un quadro più completo di ciò che fa l'azienda e di come genera profitti.

Nurix Therapeutics, Inc. paga dividendi?

Qui non mostriamo un rendimento da dividendo confermato per Nurix Therapeutics, Inc., quindi consideralo incerto: prima di scrivere delle call controlla il dividendo attuale e la data di stacco cedola (ex-dividend) presso il tuo broker — una data di stacco imminente può innescare un'assegnazione anticipata sulle call scritte in-the-money.

Quando Nurix Therapeutics, Inc. pubblica gli utili?

I prossimi utili di Nurix Therapeutics, Inc. sono attesi intorno al 8 ottobre 2026. La volatilità implicita di solito sale in avvicinamento alla pubblicazione e crolla bruscamente dopo (IV crush) — un aspetto importante per qualsiasi posizione in opzioni che mantieni oltre quella data.

Tickers related to NRIX

Comparing NRIX with similar names can help you choose the best options strategy:

KYMRKymera Therapeutics, Inc.RLAYRelay Therapeutics, Inc.CCCCC4 Therapeutics, Inc.ORICORIC Pharmaceuticals, Inc.

Informazioni sull’azienda

Sede
1600 Sierra Point Parkway, Brisbane, CA, 94005, United States
Settore
Biotechnology
Dipendenti
317
CEO
Dr. Arthur T. Sands M.D., Ph.D.
Telefono
415 660 5320
Sito web
www.nurixtx.com

Best Options Strategy by Ticker →

Solo per uso didattico. Le quotazioni sono ritardate di circa 15 minuti e nulla di ciò che è riportato qui è consulenza finanziaria. Il trading di opzioni comporta un rischio sostanziale di perdita. Privacy · Terms.